At this time, there is no known cure for plasmablastic lymphoma. Treatment typically involves a combination of chemotherapy, radiation therapy, and/or stem cell transplantation. Medications used to treat plasmablastic lymphoma may include rituximab, bendamustine, bortezomib, and lenalidomide.

1. HIV/AIDS
2. Immunosuppression
3. Chronic Epstein-Barr virus infection
4. Exposure to certain chemicals
5. Exposure to radiation
6. Age (over 60)
7. Gender (more common in males)
8. Ethnicity (more common in African Americans)
9. Certain genetic mutations

The main treatment for plasmablastic lymphoma is chemotherapy, usually in combination with other treatments such as radiation therapy, stem cell transplant, and/or targeted therapy. Depending on the stage and severity of the disease, other treatments may be recommended. In some cases, surgery may be used to remove affected lymph nodes.

The exact cause of plasmablastic lymphoma is unknown. However, it is believed to be associated with certain viruses, such as Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8). Other risk factors may include HIV infection, immunosuppression, and certain genetic mutations.

The most common symptoms of plasmablastic lymphoma include:

-Fever
-Night sweats
-Weight loss
-Enlarged lymph nodes
-Abdominal pain
-Fatigue
-Loss of appetite
-Itching
-Skin rash
-Bone pain
-Joint pain
-Shortness of breath
-Coughing
-Chest pain
-Difficulty swallowing
-Nausea and vomiting
-Diarrhea
-Blood in the stool
-Headache
-Confusion
-Depression
-Anxiety

Plasmablastic lymphoma is a rare type of non-Hodgkin lymphoma that is usually found in the oral cavity. It is an aggressive form of lymphoma that is characterized by the presence of large, abnormal plasma cells. These cells can spread to other parts of the body, including the lymph nodes, bone marrow, and other organs. Treatment typically involves chemotherapy and radiation therapy.